Companies We Back

Biotechnology research targeting chronic inflammation, with a primary focus on developing new approaches to pulmonary arterial hypertension.

Cascador Health / moveUP

Combines patient programs, clinical software and healthcare data to generate real-world evidence across the development and use of therapies.

Classcraft

Educational technology built around playful, collaborative learning experiences, designed to support student motivation and engagement in the classroom.

Kainova Therapeutics

Develops medicines targeting G protein-coupled receptors, with research and clinical programs focused on cancer immunotherapy and inflammatory diseases.

DrugBank

Connects information on drugs, targets, diseases and clinical trials to support pharmaceutical research, clinical software and drug-development decisions.

Flare

Monitors online threats, including data leaks and dark-web activity, to help organizations identify and prioritize cybersecurity risks.

Biotechnology research focused on small molecules targeting G protein-coupled receptors, with potential applications in solid cancers and inflammatory diseases.

Giiant Pharma

Develops localized therapies for gastrointestinal diseases, including ulcerative colitis, with an approach intended to limit exposure elsewhere in the body.

HypnoVR

Combines medical hypnosis with virtual reality in digital therapies designed to support pain, stress and anxiety management in healthcare settings.

Icentia

Develops wearable cardiac-monitoring devices and provides ECG analysis services to support clinicians assessing heart rhythm over extended periods.

InhaTarget Therapeutics

Develops targeted inhaled medicines for severe respiratory diseases, with an initial focus on treatment approaches for lung cancer.

Kaspard

Provides contactless fall-detection and activity-monitoring technology to help care teams understand incidents and support residents in hospitals and care homes.

Digital health company focused on using digital biomarkers to support preventive, continuous and collaborative care beyond episodic medical appointments.

Neuvasq Biotechnologies

Develops antibody therapies designed to restore blood-retina and blood-brain barriers for vascular eye diseases and neurological disorders.

Simmunome

Combines biological modelling and machine learning to simulate disease mechanisms, evaluate drug targets and identify biomarkers for drug-development decisions.

Ability Biotherapeutics

Uses artificial intelligence and antibody engineering to develop selective therapeutics targeting immune cells involved in autoimmune and inflammatory diseases.

Develops therapeutic antibodies targeting cancer-associated neoantigens, building on research aimed at new immunotherapies for difficult-to-treat pediatric leukemias.